WiseGuyReports.Com Publish a New Market Research Report On –“ Congestive Heart Failure Treatment 2019 Market By: Industry Size,Growth,Trends,Analysis,Opportunities, and Forecasts to 2023”.
Congestive Heart Failure Treatment Industry 2019
Description:-
Congestive Heart Failure Treatment market: Congestive heart failure is a chronic and progressive condition that affects the pumping capacity of heart muscles and also referred as “heart failure”. Congestive heart failure can refer to the stage in which fluid builds up around the heart and causes it to pump inefficiently. Ventricles pump blood to your body’s organs and tissues, and the atria receive blood from your body as it circulates back from the rest of your body. Congestive heart failure develops when ventricles unable to pump sufficient volume of blood to the body. Eventually, blood and other fluids can back up inside your lungs, liver, abdomen, and lower body. There are two types of congestive heart failure, they are systolic heart failure and diastolic heart failure.
Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/2868233-congestive-heart-failure-treatment-market-global-market-estimation-dynamics-regional
For more information or any query mail at sales@wiseguyreports.com
Global Congestive Heart Failure Treatment Market
Increase in prevalence of cardiovascular diseases across regions is one the major factors expected to drive the revenue growth of congestive heart failure treatment globally. Lifestyle related factors are expected to add to growing disease incidence of CVDs. In addition growing number of obese patients are expected to bolster the congestive heart failure treatment market. ast track approvals of drugs in developed countries will propel sales revenues for the companies. Huge treatment demand for congestive heart failure is expected to boost the treatment market developing. However, the availability of the generic drugs and lack of end stage pipeline drugs and therapies for congestive heart failure treatment is about to hinder the market.
Congestive Heart Failure Treatment market is segmented on the basis of the drug class, route of administration, and distribution channel
Based on drug class, congestive heart failure treatment market is segmented as
Beta Blockers
ACE Inhibitors
Angiotensin Receptor Blockers
Diuretics
Inotropic Agents
Aldosterone Antagonist
Calcium Channel Blockers
Others
Based on route of administration, congestive heart failure treatment market is segmented as
Oral
Intravenous
Based on distribution channel, congestive heart failure treatment market is segmented as
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Congestive heart failure treatment market is expected to show significant growth in demand over the forecast period owing to rising incidences of cardiovascular diseases. Congestive heart failure is one of the most common medical conditions that is responsible for the death of people globally. According to WHO, around 6.5 million of people are diagnosed with congestive heart failure every year and around 2% of global population are hospitalized due to congestive heart failure. In July, 2015, Novartis launched novel combination drug Entresto (LCZ-696) a novel branded CHF drug. The prescription of mineralocorticoid receptor antagonists (MRAs), such as spironolactone, due to their efficiency in heart failure treatment is expected to increase the Congestive heart failure (CHF) treatment markets during the forecast period. Many generic manufacturers foray into the congestive heart failure treatment market due to patent expirations of CHF innovators drugs. The presence generics expected to hinder the market revenue and may hamper the uptake of new and expected novel drugs.
Geographically congestive heart failure treatment market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America and European markets are significantly having high growth potential for congestive heart failure treatment due to the increase in incidences of heart failures in these regions. According to American Heart Association, Heart Disease and Stroke Statistics 2017, congestive heart failure occupies 8.5% of heart diseases in US. merging markets like Asia Pacific and Latin America are set to witness significant growth in this industry due to change in demographics, healthcare reforms, healthcare expenditure, and an increase in treatment for congestive heart failure conditions.
Some of the players in the global congestive heart failure (CHF) treatment market are AstraZeneca plc. (UK), Bristol-Myers Squibb Co. (U.S), GlaxoSmithKline plc (GSK) (UK), Merck & Co. Inc. (U.S), Mylan Inc. (U.S), Novartis AG (Switzerland), Pfizer Inc. (U.S), Sanofi (France), and Valeant Pharmaceuticals International Inc. (Canada)
In July 2015, U.S. Food and Drug Administration (FDA) approved Novartis, Entresto (sacubitril/valsartan) tablets, previously known as LCZ696, to treat heart failure patients with reduced ejection fraction
Report Details @ https://www.wiseguyreports.com/reports/2868233-congestive-heart-failure-treatment-market-global-market-estimation-dynamics-regional
Table Of Contents – Major Key Points
- Executive Summary
- Global Congestive Heart Failure Treatment Market Introduction
- Global Congestive Heart Failure Treatment Market Dynamics
- Global Congestive Heart Failure Treatment Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
- Global Congestive Heart Failure Treatment Market, By Drug Class, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
- Global Congestive Heart Failure Treatment Market, By Route of Administration, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
- Global Congestive Heart Failure Treatment Market, By Distribution Channel, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
- Global Congestive Heart Failure Treatment Market Forecast, By Region, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
- North America Congestive Heart Failure Treatment Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
- Europe Congestive Heart Failure Treatment Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
- Asia-Pacific Congestive Heart Failure Treatment Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
- Latin America Congestive Heart Failure Treatment Market Analysis, 2012 – 2012 – 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
Continued……
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.
Your information will never be shared with any third party.